Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01722188 · ClinicalTrials.gov registry record
Lead Registry for Optim Leads
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 14,124
- Enrollment target
NCT01722188: Completed study, sponsored by Abbott Medical Devices.
NCT01722188 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 14,124 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01722188 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 14,124 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, actively monitored, long term data collection registry. Any Patient that receives a market released St. Jude Medical (SJM) Optim lead and a compatible market released cardia rhythm management (CRM) implantable pulse generator is eligible for enrollment into the registry.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,124 participants |
| Start Date | 2006-08 |
| Est. Completion | 2020-07 |
What the finished NCT01722188 record still lists
NCT01722188 is an observational study that tracks outcomes without assigning an intervention. Its 14,124 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01722188 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01722188 about?
NCT01722188 is a clinical study titled "Lead Registry for Optim Leads". This is a prospective, multi-center, actively monitored, long term data collection registry. Any Patient that receives a market released St. Jude Medical (SJM) Optim lead and a compatible market released cardia rhythm management (CRM) implantable pulse generator is eligible for enrollment into the r...
What is the current status of trial NCT01722188?
This trial is currently completed. The enrollment target is 14,124 participants. The study started on 2006-08. Estimated completion is 2020-07.
Who is sponsoring clinical trial NCT01722188?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05591066 · 14,400 participants · NA
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
- NCT06058767 · 13,764 participants · NA
Preschool Hearing Screening
- NCT05359016 · 14,600 participants · NA
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
- NCT06849869 · 14,820 participants · NA
Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia